Cystic Fibrosis Inpatient Care Quiz

Cystic fibrosis primarily affects the respiratory system, leading to lung complications.

Cystic fibrosis is caused by mutations in the CFTR gene, leading to dysfunctional chloride ion transport.

Approximately 90% of cystic fibrosis cases are diagnosed by age 2 in the United States, enabling early intervention.

Hyperglycemia is a potential complication of cystic fibrosis-related diabetes, affecting blood sugar levels.

Vitamin D absorption is commonly impaired in individuals with cystic fibrosis, leading to potential deficiencies.

Frequent nosebleeds are not a typical symptom of cystic fibrosis; common symptoms include respiratory and digestive issues.

The sweat test is the primary diagnostic tool for cystic fibrosis, measuring elevated chloride levels in sweat.

The average life expectancy for individuals with cystic fibrosis is around 40-50 years, though this can vary.

Gastrointestinal obstruction is a common complication of cystic fibrosis, affecting the digestive system.

The CFTR gene mutation is associated with cystic fibrosis, impacting chloride ion transport.

Insulin therapy is not a common treatment for cystic fibrosis; treatments focus on respiratory and digestive support.

Pulmonary function tests are recommended every 3 months to monitor respiratory health in cystic fibrosis patients.

Ototoxicity, or hearing loss, is a potential complication of long-term antibiotic therapy in cystic fibrosis.

Percussion and postural drainage are respiratory therapies aimed at loosening mucus in the airways of cystic fibrosis patients.

Pancreatic enzyme replacement therapy is the gold standard for treating pancreatic insufficiency in cystic fibrosis.